JP2015147764A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015147764A5 JP2015147764A5 JP2015011332A JP2015011332A JP2015147764A5 JP 2015147764 A5 JP2015147764 A5 JP 2015147764A5 JP 2015011332 A JP2015011332 A JP 2015011332A JP 2015011332 A JP2015011332 A JP 2015011332A JP 2015147764 A5 JP2015147764 A5 JP 2015147764A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- less
- mmhg
- leu
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461931071P | 2014-01-24 | 2014-01-24 | |
| US61/931,071 | 2014-01-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015147764A JP2015147764A (ja) | 2015-08-20 |
| JP2015147764A5 true JP2015147764A5 (enExample) | 2018-03-01 |
| JP6624787B2 JP6624787B2 (ja) | 2019-12-25 |
Family
ID=52630418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015011332A Expired - Fee Related JP6624787B2 (ja) | 2014-01-24 | 2015-01-23 | 脳内出血を治療するための組成物および方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20160375109A1 (enExample) |
| EP (1) | EP3096779B1 (enExample) |
| JP (1) | JP6624787B2 (enExample) |
| KR (3) | KR20180014221A (enExample) |
| CN (2) | CN112156176A (enExample) |
| AU (1) | AU2015208819B2 (enExample) |
| BR (1) | BR112016014617A2 (enExample) |
| CA (1) | CA2937418A1 (enExample) |
| DK (1) | DK3096779T3 (enExample) |
| ES (1) | ES2772802T3 (enExample) |
| HU (1) | HUE047588T4 (enExample) |
| IL (1) | IL246637A0 (enExample) |
| MX (1) | MX375355B (enExample) |
| PL (1) | PL3096779T3 (enExample) |
| PT (1) | PT3096779T (enExample) |
| RU (1) | RU2016126423A (enExample) |
| SI (1) | SI3096779T1 (enExample) |
| WO (1) | WO2015110939A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2761730T3 (es) * | 2013-01-31 | 2020-05-20 | Pfizer | Composiciones y procedimientos para contrarrestar la inhibición del factor Xa |
| EP3049434A1 (en) | 2013-09-24 | 2016-08-03 | Pfizer Inc. | Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005123118A1 (en) * | 2004-06-21 | 2005-12-29 | Novo Nordisk Health Care Ag | Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage (ich) |
| MX2008006313A (es) | 2005-11-15 | 2008-11-06 | Philadelphia Children Hospital | Metodos y composiciones para modular la hemostasia. |
| JP2011509978A (ja) * | 2008-01-18 | 2011-03-31 | ノボ ノルディスク ヘルス ケア アーゲー | 選択されたＩＣＨ患者亜集団における脳内出血（ＩＣＨ）後の出血拡大、及び／又は浮腫生成の予防又は減弱のための、第ＶＩＩａ因子又は第ＶＩＩａ因子等価物の使用 |
| ES2605801T3 (es) * | 2009-07-15 | 2017-03-16 | Portola Pharmaceuticals, Inc. | Formulación de dosis unitaria de antídoto para inhibidores del factor Xa para su uso en la prevención de la hemorragia |
| WO2011020866A2 (en) * | 2009-08-20 | 2011-02-24 | Csl Behring Gmbh | Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| US9371522B2 (en) * | 2011-09-30 | 2016-06-21 | The Children's Hospital Of Philadelphia | Compositions and methods for modulating hemostasis |
| WO2014018120A1 (en) * | 2012-07-25 | 2014-01-30 | Catalyst Biosciences, Inc. | Modified factor x polypeptides and uses thereof |
| ES2761730T3 (es) * | 2013-01-31 | 2020-05-20 | Pfizer | Composiciones y procedimientos para contrarrestar la inhibición del factor Xa |
-
2015
- 2015-01-15 BR BR112016014617A patent/BR112016014617A2/pt not_active IP Right Cessation
- 2015-01-15 WO PCT/IB2015/050313 patent/WO2015110939A1/en not_active Ceased
- 2015-01-15 CA CA2937418A patent/CA2937418A1/en not_active Abandoned
- 2015-01-15 AU AU2015208819A patent/AU2015208819B2/en not_active Ceased
- 2015-01-15 KR KR1020187002632A patent/KR20180014221A/ko not_active Ceased
- 2015-01-15 CN CN202011260045.4A patent/CN112156176A/zh active Pending
- 2015-01-15 US US15/112,088 patent/US20160375109A1/en not_active Abandoned
- 2015-01-15 KR KR1020167019778A patent/KR20160093731A/ko not_active Ceased
- 2015-01-15 EP EP15708578.8A patent/EP3096779B1/en not_active Not-in-force
- 2015-01-15 CN CN201580005696.XA patent/CN105934250A/zh active Pending
- 2015-01-15 PT PT157085788T patent/PT3096779T/pt unknown
- 2015-01-15 RU RU2016126423A patent/RU2016126423A/ru not_active Application Discontinuation
- 2015-01-15 MX MX2016009665A patent/MX375355B/es active IP Right Grant
- 2015-01-15 HU HUE15708578A patent/HUE047588T4/hu unknown
- 2015-01-15 DK DK15708578.8T patent/DK3096779T3/da active
- 2015-01-15 ES ES15708578T patent/ES2772802T3/es active Active
- 2015-01-15 PL PL15708578T patent/PL3096779T3/pl unknown
- 2015-01-15 KR KR1020217001254A patent/KR20210008177A/ko not_active Ceased
- 2015-01-15 SI SI201531081T patent/SI3096779T1/sl unknown
- 2015-01-23 JP JP2015011332A patent/JP6624787B2/ja not_active Expired - Fee Related
-
2016
- 2016-07-06 IL IL246637A patent/IL246637A0/en unknown
-
2018
- 2018-10-11 US US16/157,194 patent/US20190231856A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ge et al. | The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury | |
| US9162975B2 (en) | Phenyl carbamate compounds for use in alleviating or treating pain | |
| RU2707191C2 (ru) | Нейродегенеративные расстройства | |
| JP2010532761A5 (enExample) | ||
| Zagrebelsky et al. | Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor? | |
| Li et al. | Intranasal delivery of FSD‐C 10, a novel R ho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis | |
| JP2022511568A5 (enExample) | ||
| JP2021530570A (ja) | てんかん、発作および中枢神経系障害を治療するための経口抗炎症性ペプチド | |
| JP2008521796A5 (enExample) | ||
| BR112022009898A2 (pt) | Composições e métodos para desrepressão de genes alvo do fator de transcrição silenciador de re1 | |
| JP2015147764A5 (enExample) | ||
| Zhang et al. | (R, S)-ketamine promotes striatal neurogenesis and sensorimotor recovery through improving poststroke depression–mediated decrease in atrial natriuretic peptide | |
| Xu et al. | Beneficial effects of local profound hypothermia and the possible mechanism after experimental spinal cord injury in rats | |
| Tang et al. | TREM2 alleviates long-term cognitive dysfunction after subarachnoid hemorrhage in mice by attenuating hippocampal neuroinflammation via PI3K/Akt signaling pathway | |
| Perasso et al. | In vivo neuroprotection by a creatine-derived compound: Phosphocreatine–Mg-complex acetate | |
| TWI496579B (zh) | 類鋅手指胜肽、其表現質體、及包含其之醫藥組成物之用途 | |
| Bellani et al. | Diffusion imaging studies of white matter integrity in bipolar disorder | |
| RU2016126423A (ru) | Композиции и способы лечения внутримозгового кровоизлияния | |
| US20170252403A1 (en) | Methods and compositions for treating retinal disorders | |
| US20080045611A1 (en) | Methods for the therapeutic use of a carbonic anhydrase inhibitor for reducing spinal cord edema | |
| TWI306770B (en) | Pharmaceutical composition for rescuring learning or memory deficits | |
| RU2013139704A (ru) | Применение белка yb-1 и его фрагментов для изготовления лекарственных средств при лечении болезни альцгеймера | |
| Czlonkowska | THE CLINICAL DEVELOPMENT OF CEREBROLYSIN: NEW APPROACHES IN STROKE STUDIES. A COMMENTARY TO THE CARS STUDY | |
| Dovgiy et al. | Rehabilitation of patients suffering from ischemic stroke by methods of ozonotherapy, kinesitherapy, physiotherapy and acupuncture | |
| CA2968933C (en) | Peptides for use in neurodegenerative disorders |